despit
recent
success
biolog
agent
therapi
autoimmun
inflammatori
diseas
rheumatoid
arthriti
ra
mani
patient
fail
respond
adequ
treatment
make
continu
search
new
therapi
extrem
import
recent
prevail
hypothesi
reactiv
oxygen
speci
ro
promot
inflamm
challeng
polymorph
decreas
oxid
burst
shown
increas
diseas
sever
mous
rat
arthriti
model
base
find
develop
new
therapi
arthriti
use
oxid
burstinduc
substanc
treatment
rat
phytol
increas
oxid
burst
vivo
therebi
correct
effect
genet
polymorph
arthritispron
da
rat
importantli
phytol
treatment
also
decreas
autoimmun
respons
amelior
acut
chronic
phase
arthriti
compar
standard
therapi
ra
antitumour
necrosi
factora
methotrex
phytol
show
equal
good
better
therapeut
properti
final
phytol
mediat
effect
within
hour
administr
involv
modul
cell
activ
inject
prevent
adopt
transfer
diseas
arthritogen
cell
treatment
arthriti
rospromot
substanc
phytol
target
newli
discov
pathway
lead
autoimmun
inflammatori
diseas
introduc
novel
class
therapeut
treatment
ra
possibl
chronic
inflammatori
diseas
rheumatoid
arthriti
ra
complex
chronic
inflammatori
diseas
depend
multipl
interact
environment
genet
factor
make
difficult
understand
pathogenesi
therebi
find
effect
therapi
therapi
ra
mainli
base
methotrex
mtx
biolog
agent
directli
target
molecul
involv
pathogenesi
raeg
human
solubl
tumour
necrosi
factor
receptor
etanercept
enbrel
howev
cytokin
target
biolog
agent
also
play
gener
role
immun
defenc
risk
infect
increas
use
agent
therefor
continu
search
success
therapi
ra
extrem
import
diseasecaus
mechan
underli
ra
target
prevent
therapeut
treatment
difficult
identifi
addit
search
gene
predispos
autoimmun
far
limit
success
recent
neutrophil
cytosol
factor
identifi
posit
clone
gene
control
arthriti
sever
rat
alia
import
subunit
nadph
oxidas
complex
respons
oneelectron
reduct
oxygen
ultim
yield
reactiv
oxygen
speci
ro
oxid
burst
process
use
phagocyt
primarili
kill
invad
pathogen
surpris
find
polymorph
suscept
dark
agouti
da
rat
increas
suscept
arthriti
associ
low
oxid
burst
capac
contradict
hypothesi
current
use
high
level
free
radic
promot
inflamm
find
led
us
propos
substanc
increas
activ
nadph
oxidas
complex
could
amelior
possibl
prevent
sever
arthriti
studi
use
rat
experiment
model
ra
identifi
compound
increas
oxid
burst
capac
vivo
investig
whether
substanc
therebi
could
therapeut
effect
arthriti
rat
strain
da
zentralinstitut
r
versuchstierzucht
hannov
germani
kept
climatecontrol
environ
h
lightdark
cycl
hous
polystyren
cage
contain
wood
shave
fed
standard
rodent
chow
water
ad
libitum
anim
hous
medic
inflamm
research
http
wwwinflam
luse
rat
found
free
common
pathogen
includ
sendai
viru
hantaan
viru
coronaviru
reoviru
cytomegaloviru
mycoplasma
pulmonali
strain
describ
experi
approv
local
lund
sweden
ethic
committe
licens
human
promyelocyt
line
atcc
manassa
virginia
unit
state
cultur
dmem
gibco
paisley
uk
complement
hepe
fetal
calf
serum
penicillinstreptomycin
standard
cell
cultur
concentr
cell
differenti
granulocyt
cultur
presenc
dmso
sigmaaldrich
st
loui
missouri
unit
state
assay
cell
wash
resuspend
dpb
gibco
concentr
cellsml
satur
alkan
molecul
larodan
fine
chemic
ab
sweden
pristan
phytol
sigmaaldrich
test
oxid
burstinduc
capac
accord
previous
describ
method
oil
solubil
dilut
concentr
bcyclodextrin
sigmaaldrich
pb
bcyclodextrin
stimul
effect
ro
product
briefli
resuspend
oil
ad
plate
contain
cellswel
total
volum
pb
contain
isoluminol
horseradish
peroxidas
final
isoluminol
concentr
mgml
sigmaaldrich
horseradish
peroxidas
type
ii
unitsml
sigmaaldrich
sampl
gentli
mix
data
collect
initi
immedi
extracellular
ro
product
follow
luminesc
signal
fluostar
optima
bmg
labtechnolog
offenburg
germani
present
maxim
rel
signal
measur
period
min
diseas
induc
rat
age
wk
rat
sexand
agematch
within
experi
pristaneinduc
arthriti
pia
oilinduc
arthriti
induc
subcutan
sc
inject
base
tail
pristan
alkan
oil
collageninduc
arthriti
cia
induc
sc
inject
rat
collagen
type
ii
cii
lg
rat
purifi
swarm
rat
chondrosarcoma
previous
describ
emulsifi
ifa
difco
bd
diagnost
system
maryland
unit
state
nonoil
collageninduc
arthriti
nocia
induc
emulsifi
rat
cii
lg
mixtur
lp
lg
sigmaaldrich
cpg
atg
acg
ttc
ctg
acg
lg
mwgbiotech
ag
ebersberg
germani
alum
mg
sigmaaldrich
inject
sc
total
volum
arthriti
develop
monitor
macroscop
score
system
four
limb
rang
one
point
swollen
red
toe
one
point
midfoot
digit
knuckl
five
point
swollen
ankl
score
four
paw
ad
yield
maximum
total
score
rat
unless
state
otherwis
prevent
treatment
arthriti
perform
sc
inject
phytol
induct
arthriti
control
rat
left
untreat
therapeut
treatment
administ
sc
intraperiton
ip
onset
diseas
acut
chronic
phase
comparison
standard
treatment
perform
inject
phytol
sc
etanercept
gener
provid
prof
h
burkhart
erlangen
germani
mg
kg
pb
sc
mtx
wyeth
lederl
solna
sweden
mg
mtxkg
rat
ip
day
total
volum
treatment
adopt
transfer
perform
inject
phytol
sc
recipi
h
transfer
donor
rat
treat
phytol
sc
day
h
spleen
isol
level
intracellular
oxid
burst
ex
vivo
measur
prepar
singlecel
suspens
blood
spleen
drain
lymph
node
ln
bone
marrow
bm
red
blood
cell
lyse
ammonium
chlorid
ph
concentr
oxid
burst
granulocyt
cell
determin
incub
cell
min
biotinlabel
antibodi
antigranulocyt
percplabel
antibodi
antit
cell
receptor
bd
bioscienc
pharmingen
san
jose
california
unit
state
wash
pb
cell
incub
allophycocyaninconjug
streptavidin
bd
pharmingen
min
determin
level
nadph
activ
use
modifi
version
oxid
burst
activ
flow
cytometri
assay
previous
describ
briefli
cell
resuspend
dulbecco
complet
medium
without
fc
stain
incub
min
lm
molecular
probe
leiden
netherland
oxid
hydrogen
peroxid
h
peroxinitrit
onoo
hydroxyl
radic
oh
emit
bright
fluoresc
signal
upon
excit
blue
light
cell
stimul
ngml
phorbol
pma
sigmaaldrich
min
wash
pb
acquir
facsort
bd
bioscienc
gate
celltyp
fluoresc
intens
measur
result
express
rel
fluoresc
unit
blood
collect
nonheparin
tube
serum
isol
centrifug
level
lipid
peroxid
measur
modifi
version
malonedialdehydethiobarbitur
acid
method
previous
describ
brief
mixtur
contain
thiobarbitur
acid
sigmaaldrich
tca
hcl
freshli
prepar
ethanol
ad
serum
togeth
reaction
mix
mix
vigor
sampl
incub
min
centrifug
rpm
min
absorb
supernat
measur
nm
spectra
max
molecular
devic
sunnyval
california
unit
state
blood
spleen
drain
ln
taken
rat
sc
inject
phytol
singlecel
suspens
prepar
red
blood
cell
lyse
ammonium
chlorid
ph
remain
cell
wash
pb
stain
antibodi
antit
cell
receptor
bd
pharmingen
cell
acquir
facsort
bd
bioscienc
btot
cell
ratio
well
ratio
determin
gate
respect
cell
type
order
determin
total
antibodi
level
plate
maxisorp
nunc
roskild
denmark
coat
antiigg
zyme
san
francisco
california
unit
state
antiigm
bd
pharmingen
pb
overnight
plate
block
h
room
temperatur
bsa
sigmaaldrich
plasma
dilut
pb
ad
level
antibodi
detect
use
biotinyl
antiigg
zyme
antiigm
antibodi
bd
pharmingen
follow
incub
peroxidaseconjug
streptavidin
abt
tablet
roch
diagnost
gmbh
mannheim
germani
result
analyz
spectra
max
od
nm
molecular
devic
rel
amount
antibodi
compar
pool
posit
control
blood
spleen
drain
ln
taken
da
rat
h
inject
intraderm
phytol
singlecel
suspens
prepar
red
blood
cell
lyse
ammonium
chlorid
ph
cell
wash
pb
stain
bd
pharmingen
min
cell
resuspend
pb
contain
annexin
v
bd
pharmingen
lgml
propidium
iodid
pi
molecular
probe
wash
cell
acquir
facsort
bd
bioscienc
percentag
apoptot
annexin
v
pi
necrot
annexin
v
pi
cell
determin
antibodi
titr
cii
plasma
determin
elisa
plate
maxisorp
coat
overnight
lgml
rat
cii
pb
per
well
wash
perform
use
pb
contain
tween
plasma
dilut
pb
analyz
duplic
amount
bound
igg
antibodi
estim
incub
biotinconjug
isotypespecif
antibodi
zyme
follow
peroxidaseconjug
streptavidin
abt
roch
diagnost
substrat
follow
detect
spectra
max
nm
molecular
devic
rel
amount
antibodi
plasma
determin
comparison
posit
control
pool
serum
day
nocia
immun
rat
challeng
lg
cii
acet
acid
inject
epidermi
right
extern
ear
acet
acid
inject
left
ear
control
delayedtyp
hypersensit
dth
respons
measur
h
differ
swell
right
left
ear
percent
plasma
concentr
cartilag
oligomer
matrix
protein
comp
determin
competit
elisa
describ
previous
briefli
rat
comp
use
coat
microtitr
plate
prepar
standard
curv
includ
plate
plate
block
bsa
pb
ad
plasma
comp
level
detect
use
rabbit
polyclon
antiserum
rat
comp
gener
provid
professor
dick
rd
lund
sweden
amount
serum
comp
estim
incub
alkalin
phosphataseconjug
isotypespecif
antibodi
dako
glostrup
denmark
phosphatas
substrat
sigmaaldrich
follow
detect
spectramax
molecular
devic
od
nm
rat
inject
phytol
sc
day
induct
diseas
inject
pristan
day
half
phytoltr
rat
inject
histamin
dihydrochlorid
sigmaaldrich
sc
mgml
ip
mgml
total
mg
histamin
dihydrochloriderat
rat
inject
way
day
pristan
control
rat
left
untreat
da
rat
inject
either
phytol
pristan
pristan
alon
day
sc
half
pristaneinject
rat
treat
phytol
sc
day
rat
sacrif
day
paw
taken
histolog
analysi
sampl
fix
phosphatebuff
paraformaldehyd
decalcifi
edta
embed
paraffin
section
stain
erythrosinehematoxylin
magnifi
da
rat
spleen
collect
homogen
inject
pristan
red
blood
cell
lyse
ammonium
chlorid
ph
remain
cell
wash
pb
cultur
dmem
gibco
contain
concanavalin
sigmaaldrich
h
wash
resuspend
pb
cell
inject
ip
phytoltr
da
rat
cellsrat
quantit
data
express
mean
standard
error
mean
signific
analysi
perform
use
mannwhitney
test
result
compar
control
group
unless
otherwis
indic
sinc
low
oxid
burst
capac
increas
arthriti
suscept
propos
substanc
elev
ro
product
could
therapeut
effect
arthriti
alreadi
seen
certain
oil
alkan
structur
phytol
pristan
oxid
burstinduc
capac
vitro
addit
despit
structur
similar
pristan
induc
arthriti
wherea
phytol
protect
examin
structurefunct
relationship
screen
number
short
satur
alkan
use
isoluminolbas
oxid
burst
assay
human
promyelocyt
differenti
granulocyt
presenc
dmso
alkan
carbon
long
potent
activ
nadph
oxidas
complex
figur
investig
arthritogen
potenti
inject
alkan
arthritissuscept
da
rat
carri
da
allel
da
alkan
carbon
pristan
induc
arthriti
wherea
shorter
alkan
figur
therefor
conclud
arthritisinduc
effect
oil
independ
oxid
burstinduc
capac
next
want
see
oxid
burstinduc
effect
correl
arthriti
prevent
use
pia
model
human
ra
shown
induc
oxid
burst
vitro
potent
reduc
arthriti
sever
administ
arthriti
induct
figur
similar
result
also
seen
unpublish
data
contrast
arthritogen
increas
oxid
burst
protect
arthriti
figur
result
clearli
demonstr
small
chang
structur
determin
effect
molecul
sinc
phytol
superior
induc
oxid
burst
vitro
well
prevent
arthriti
inject
induct
diseas
figur
chosen
studi
efficaci
investig
depend
arthritisprev
effect
rout
administr
phytol
administ
sc
ip
intranas
pia
induct
evid
sc
administr
result
best
prevent
effect
figur
also
want
know
whether
phytol
oxid
burstinduc
effect
vivo
particular
ask
whether
phytol
would
correct
low
oxid
burst
capac
seen
rat
carri
da
allel
analyz
spleen
granulocyt
phytol
inject
intracellular
oxid
burst
respons
pma
stimul
vitro
phytol
clearli
increas
oxid
burst
capac
da
rat
level
congen
rat
carri
arthritisprotect
allel
figur
serum
level
malondialdehyd
main
product
lipid
peroxid
also
increas
phytol
inject
figur
reflect
higher
level
oxid
vivo
sinc
singl
phytol
inject
mediat
surprisingli
long
suppress
arthriti
figur
investig
whether
protect
effect
correl
sustain
increas
oxid
burst
capac
thu
follow
oxid
burst
respons
pma
blood
granulocyt
wk
inject
either
pristan
phytol
order
avoid
intraexperi
variat
result
normal
standard
group
increas
oxid
burst
capac
evid
day
phytol
pristan
inject
persist
sever
week
figur
develop
arthriti
pma
respons
pristaneinject
rat
increas
compar
rat
possibl
reflect
system
respons
local
inflamm
find
agre
report
oxygen
radic
synovi
neutrophil
human
ra
one
possibl
explan
longlast
effect
phytol
could
phenotyp
cell
popul
longer
lifespan
neutrophil
granulocyt
stem
cell
bm
alter
address
hypothesi
analyz
bm
cell
da
rat
h
phytol
effect
inject
seen
h
h
administr
phytol
oxid
burst
capac
elev
level
protect
rat
figur
next
investig
effect
phytol
vivo
blood
spleen
drain
ln
five
day
inject
cell
differ
anatom
site
collect
analyz
oxid
burst
phytol
clearli
increas
background
activ
granulocyt
also
pma
stimul
phytolprim
granulocyt
higher
respons
capac
figur
wherea
cell
show
bare
detect
increas
ro
product
figur
compar
level
oxid
burst
granulocyt
cell
minor
produc
ro
figur
cell
also
stimul
platebound
increas
ro
product
figur
increas
cell
oxid
burst
could
reflect
contamin
ro
granulocyt
bt
cell
ratio
alter
phytol
inject
figur
presum
increas
b
cell
number
tendenc
toward
higher
level
igg
igm
also
seen
figur
tendenc
seen
phytol
treatment
pia
unpublish
data
altern
increas
bt
ratio
could
result
decreas
cell
number
phytol
significantli
alter
cell
distribut
effect
ratio
seen
unpublish
data
investig
whether
chang
cell
distribut
due
phytol
toxic
analyz
percentag
apoptot
necrot
cell
ex
vivo
inject
level
dead
cell
increas
figur
suggest
increas
bt
ratio
diseaseprev
effect
mediat
via
increas
deplet
cell
sinc
pia
model
uniqu
pathogenesi
involv
abt
cell
oper
effector
phase
well
analyz
whether
phytol
oper
also
cia
model
antibodi
import
joint
inflammatori
attack
signific
decreas
arthriti
sever
compar
effect
pia
observ
prevent
administr
phytol
also
cia
figur
importantli
phytol
suppress
autoimmun
respons
plasma
level
cii
specif
antibodi
day
immun
reduc
figur
level
anticii
isotyp
decreas
phytol
treatment
also
igm
respons
lower
figur
suggest
shift
cell
respons
howev
total
igg
igm
level
affect
figur
argu
specif
effect
phytol
ciireact
cell
igg
anticii
respons
celldepend
data
indic
lower
activ
cii
autoreact
helper
cell
far
arthriti
induc
oil
compon
pristan
ifa
cii
immun
exclud
role
oil
induct
diseas
develop
new
model
nocia
cii
emulsifi
mixtur
nonoil
adjuv
alum
lipopolysaccharid
bacteri
dna
sequenc
cpg
inject
sc
phytol
inject
immun
complet
block
develop
diseas
figur
addit
immun
system
challeng
end
experi
day
nocia
induct
cii
inject
ear
found
phytol
total
inhibit
dth
respons
figur
consid
new
candid
therapi
ra
human
phytol
need
therapeut
effect
establish
arthriti
thu
test
efficaci
phytol
acut
chronic
phase
pia
test
phytol
acut
phase
rat
treat
twice
inject
start
peak
diseas
around
day
phytol
inject
markedli
decreas
arthriti
sever
figur
decreas
circul
compa
measur
ongo
cartilag
destruct
occur
treatment
figur
determin
therapeut
effici
chronic
phase
pia
phytol
inject
two
time
inject
start
diseas
pass
first
phase
relaps
observ
around
day
chronic
phase
quit
differ
acut
phase
control
differ
set
gene
importantli
signific
decreas
arthriti
sever
treat
rat
observ
figur
result
clearli
show
phytol
prevent
effect
therapeut
along
diseas
cours
histopatholog
analysi
paw
rat
treat
either
acut
phase
pia
reveal
effect
inflamm
joint
destruct
figur
section
taken
rat
treat
acut
phase
diseas
mild
inflamm
could
seen
togeth
remnant
earlier
sever
inflamm
rat
treat
onset
show
sign
inflamm
investig
whether
phytol
effect
depend
uniqu
da
genet
background
induc
arthriti
rat
also
develop
chronic
arthriti
high
incid
rat
lower
oxid
burst
protect
rat
caus
allel
carri
da
da
rat
rat
also
protect
arthriti
prevent
phytol
inject
figur
treatment
oxid
burst
induc
thu
far
done
increas
ro
product
da
rat
next
want
investig
whether
rat
express
allel
could
treat
success
phytol
sinc
shown
one
allel
enough
restor
oxid
burst
prevent
arthriti
da
rat
use
da
doubl
congen
rat
strain
express
also
congen
fragment
chromosom
allow
arthriti
develop
also
rat
phytol
treatment
acut
phase
diseas
result
signific
decreas
diseas
sever
figur
import
find
indic
phytol
also
therapeut
individu
normal
oxid
burst
capac
import
issu
new
therapi
whether
effect
revers
select
histamin
block
oxid
burst
respons
granulocyt
vivo
histamin
dihydrochlorid
inject
amelior
effect
phytol
arthriti
sever
revers
figur
highlight
import
ro
therapeut
effect
mtx
often
first
choic
therapi
ra
mani
case
use
combin
blocker
tumour
necrosi
factora
key
cytokin
ra
etanercept
first
compar
effici
phytol
etanercept
cia
model
tumour
necrosi
factora
blocker
previous
shown
good
effect
rat
phytol
etanercept
administ
sc
day
highli
effect
reduc
cia
figur
pia
model
prevent
mediat
phytol
even
pronounc
etanercept
figur
furthermor
signific
reduct
diseas
sever
could
seen
singl
etanercept
administr
stage
diseas
phytol
significantli
lower
diseas
score
unpublish
data
also
comparison
mtx
phytol
valid
potenti
therapeut
agent
figur
phytol
effect
differ
stage
arthriti
thu
want
investig
phytol
actual
oper
stagespecif
way
rather
longterm
effect
possibl
address
question
sinc
pia
transfer
cell
shown
spleen
cell
collect
pristan
administr
cultur
presenc
concanavalin
transfer
recipi
rat
arthritogen
cell
abt
cell
introduc
good
tool
studi
effect
increas
oxid
burst
cell
address
question
whether
phytol
prevent
therapeut
effect
adopt
transfer
pia
pretreat
recipi
rat
transfer
arthritogen
cell
found
equal
good
prevent
result
arthriti
treatment
figur
addit
want
know
whether
phytol
effect
vivo
activ
arthritogen
cell
therefor
donor
rat
treat
phytol
prior
spleen
isol
almost
complet
blockag
diseas
could
seen
rat
transfer
cell
phytolpretr
day
rat
figur
suggest
phytolmedi
inhibit
arthritogen
cell
determin
inhibitori
effect
arthritogen
cell
import
inject
phytol
donor
differ
time
point
pristan
ie
day
follow
pristan
inject
h
sacrific
donor
splenocyt
analyz
oxid
burst
day
rat
given
phytol
sacrific
higher
level
intrins
oxid
burst
without
pma
stimul
vitro
figur
differ
oxid
burst
seen
pma
stimul
possibl
due
proxim
arthriti
onset
unpublish
data
interestingli
none
rat
receiv
cell
phytoltr
donor
develop
arthriti
even
phytol
treatment
given
late
h
sacrific
figur
togeth
observ
increas
oxid
burst
capac
occur
spleen
cell
rat
argu
rosproduc
cell
affect
arthritogen
cell
vitro
nadph
oxidas
activ
transfer
recipi
howev
oxid
burst
measur
recipi
transfer
differ
seen
unpublish
data
recipi
rat
reimmun
pristan
group
develop
arthriti
unpublish
data
exclud
transfer
regulatori
cell
exclud
influenc
cell
oxid
burstproduc
cell
vitro
mix
cell
cultur
control
rat
rat
treat
day
rat
transfer
cell
mix
develop
arthriti
figur
although
half
number
arthritogen
cell
transfer
suggest
domin
phenotyp
exclud
apoptosisinduc
effect
analyz
blood
spleen
drain
ln
cell
death
h
phytol
inject
apoptosi
increas
phytol
agreement
data
treatment
phytol
even
seem
protect
necrosi
figur
exclud
acut
cell
deathinduc
effect
treatment
experi
clearli
show
phytol
exercis
rapid
regulatori
effect
arthritogen
cell
prime
secondari
activ
stage
vivo
result
show
arthriti
suppress
mediat
increas
oxid
burst
vivo
open
chronic
inflammatori
diseas
pathway
possibl
target
therapeut
new
therapeut
approach
base
revers
phenotyp
caus
genet
polymorph
respons
increas
sever
arthriti
rat
mice
increas
possibl
also
oper
similarli
human
rosinduc
compound
phytol
show
compar
better
therapeut
effect
comparison
two
major
drug
use
ra
today
ie
etanercept
mtx
confirm
possibl
therapeut
efficaci
phytol
success
amelior
arthriti
rat
low
ro
product
also
rat
normal
oxid
burst
respons
rat
differ
genet
background
differ
model
pia
cia
nocia
adopt
transfer
model
taken
togeth
data
suggest
sever
subtyp
heterogen
diseas
ra
could
treat
use
approach
gener
ro
thought
play
major
role
defenc
invad
pathogen
complet
lack
ro
due
defici
result
chronic
granulomat
diseas
mice
human
patient
chronic
granulomat
diseas
suffer
granulomat
inflammatori
diseas
also
increas
suscept
infect
observ
increas
arthriti
sever
low
burstrespond
rat
could
influenc
increas
infect
suscept
believ
case
observ
pathogen
infect
rat
also
preliminari
data
suggest
mice
mutat
show
similar
arthriti
suscept
convent
spf
condit
unpublish
data
like
investig
polymorph
differ
effect
compar
complet
delet
caus
chronic
granulomat
diseas
recent
ro
thought
act
invad
pathogen
also
play
import
regulatori
role
immun
system
although
granulocyt
main
rosproduc
cell
type
prevent
effect
arthritogen
cell
could
clearli
seen
treatment
prevent
effect
could
mediat
sever
differ
stage
shown
coincub
cell
rosproduc
granulocyt
inhibit
cytokin
product
also
cell
expans
apoptosi
affect
alter
level
oxygen
radic
increas
ro
product
seen
phytol
treatment
could
addit
chang
gener
oxid
statu
cell
therebi
mediat
suppress
oxid
protein
cell
surfac
shown
crucial
function
eg
protein
lat
linker
activ
cell
highli
sensit
redox
alter
result
lower
cell
receptor
signal
oxid
reduc
environ
also
shown
import
cell
prolifer
cell
propos
express
compon
nadph
oxidas
complex
produc
ro
measur
increas
oxid
burst
cell
phytol
treatment
dramat
lower
level
granulocyt
increas
ro
could
result
ro
leak
surround
granulocyt
produc
oxid
burst
mechan
independ
could
exclud
howev
possibl
cell
oxid
burst
effect
autoimmun
cell
like
regul
ro
produc
extracellularli
cell
activ
antigenpres
cell
granulocyt
well
intern
mitochondri
activ
exampl
protein
tyrosin
phosphatas
regul
wide
array
cellular
signal
pathway
inactiv
oxid
interest
polymorph
shown
associ
sever
chronic
inflammatori
diseas
includ
ra
mutat
lead
potent
neg
effect
cell
receptor
signal
akin
envis
reduc
cystein
combin
site
protein
tyrosin
phosphatas
ro
also
directli
act
second
messeng
signal
pathwaysfor
exampl
signalregul
protein
kinas
signal
cascad
effect
phytol
could
mediat
indirectli
shown
oxid
phospholipid
could
block
tolllik
receptormedi
activ
dendrit
cell
macrophag
limit
capac
stimul
cell
therebi
suggest
regulatori
feedback
mechan
increas
oxid
burst
phytol
restrict
one
anatom
compart
observ
blood
bm
spleen
ln
thymu
could
also
affect
treatment
alter
oxid
statu
could
affect
deplet
autoreact
cell
activ
threshold
autoreact
cell
result
lower
level
autoreact
ultim
phytol
affect
develop
arthritogen
cell
rapidli
earli
h
phytol
inject
longer
possibl
transfer
diseas
pristaneinject
rat
arthritisprevent
effect
adopt
transfer
probabl
oper
downregul
arthritogen
cell
mediat
rosproduc
cell
vitro
recipi
sinc
mix
treat
untreat
cell
transfer
arthriti
alter
oxid
burst
occur
recipi
transfer
earli
prevent
effect
seen
phytol
like
mediat
via
induct
oxid
burst
cell
sinc
effect
lost
phytolprim
cell
cultur
togeth
arthritogen
cell
find
also
exclud
transfer
regulatori
cell
sinc
recipi
develop
pia
normal
manner
c
phytol
inhibit
arthritogen
cell
inject
donor
da
rat
spleen
cell
phytol
treat
sc
day
rat
taken
day
pristan
inject
transfer
da
rat
effect
phytol
develop
arthritogen
cell
follow
n
e
phytol
rapid
inhibitori
effect
arthritogen
cell
timepoint
effect
phytol
titrat
administr
phytol
sc
differ
day
pristan
inject
day
day
pristan
donor
spleen
da
taken
analyz
oxid
burst
granulocyt
n
cell
transfer
da
recipi
rat
rat
monitor
arthriti
symptom
e
cell
rat
treat
day
control
rat
also
mix
investig
possibl
domin
effect
phytol
treatment
control
cnt
n
phytol
n
mix
n
f
phytol
induc
acut
cell
death
percentag
apoptot
annexin
necrot
annexin
cell
ex
vivo
h
phytol
n
p
p
p
doi
data
provid
new
strategi
prevent
amelior
establish
arthriti
previous
littlestudi
pathway
involv
protect
oxid
burst
treatment
effect
differ
arthriti
rat
model
differ
rat
strain
differ
stage
diseas
regul
differ
gene
mechan
thu
phytol
repres
promis
new
class
pharmaceut
investig
treatment
chronic
inflammatori
diseas
figur
stimul
cell
phytolinject
rat
cell
taken
differ
anatom
site
phytol
inject
follow
lysi
red
blood
cell
remain
cell
stain
cell
receptor
incub
platebound
background
rheumatoid
arthriti
ra
chronic
ill
affect
peopl
worldwid
caus
pain
swell
joint
tendon
tissu
frequent
lead
perman
deform
disabl
ra
involv
abnorm
attack
cell
immun
system
bodi
connect
tissu
socal
autoimmun
current
drug
ra
work
counteract
molecul
caus
pain
swell
inflamm
reduc
sever
autoimmun
inflamm
drug
may
also
reduc
diseas
longterm
damag
joint
inflamm
alway
abnorm
fact
play
import
part
bodi
defens
infect
part
activ
diseasecaus
bacteria
white
blood
cell
known
granulocyt
gener
reactiv
oxygen
speci
ro
sometim
known
free
radic
engulf
invad
bacteria
neutrophil
releas
oxid
burst
rosessenti
subcellular
equival
pour
hydrogen
peroxid
wound
disinfect
complex
molecul
known
collect
nadph
oxidas
complex
specif
function
gener
ro
fuel
oxid
burst
interestingli
recent
experi
arthritispron
rat
found
anim
alter
form
one
subunit
complex
decreas
product
ro
also
greater
suscept
arthriti
find
surpris
free
radic
gener
associ
inflamm
longterm
damag
cell
reduct
ro
might
expect
decreas
suscept
inflammatori
diseas
like
ra
studi
done
mani
patient
autoimmun
inflammatori
ill
like
ra
respond
current
avail
therapi
new
approach
treatment
merit
investig
base
observ
associ
reduc
ro
increas
suscept
arthriti
research
want
find
whether
treatment
compound
increas
ro
product
nadph
oxidas
complex
would
caus
improv
arthriti
research
find
research
test
compound
call
phytol
arthritispron
rat
see
affect
inflamm
known
arthriti
induc
rat
inject
oil
call
pristan
research
found
phytol
caus
strong
oxid
burst
human
granulocyt
cell
grown
laboratori
caus
arthriti
rat
wherea
pristan
caus
arthriti
caus
lower
oxid
burst
granulocyt
studi
whether
phytol
prevent
arthriti
rat
found
rat
inject
phytol
protect
arthriti
follow
later
inject
pristan
given
result
want
know
phytol
increas
ro
rat
laboratori
cell
cultur
studi
granulocyt
taken
rat
treat
phytol
found
oxid
burst
cell
inde
increas
remain
increas
sever
week
treatment
went
test
phytol
treatment
activ
arthriti
found
dramat
reduc
swollen
joint
destruct
cartilag
given
rat
acut
pristaneinduc
arthriti
benefici
effect
phytol
seen
rat
bred
form
produc
abnorm
low
amount
ro
also
rat
whose
granulocyt
produc
normal
oxid
burst
compar
rat
drug
licens
ra
etanercept
methotrex
phytol
appear
least
effect
activ
phytol
arthriti
shown
involv
lymphocyt
inject
phytol
inhibit
transfer
pristaneinduc
arthriti
cell
find
mean
experi
rais
intrigu
possibl
entir
new
modal
treat
autoimmun
diseas
name
drug
design
increas
product
ro
studi
rais
number
practic
scientif
issu
exampl
known
whether
reduc
capac
produc
ro
signific
factor
human
ra
also
connect
ro
product
granulocyt
autoimmun
arthriti
involv
activ
lymphocyt
remain
clarifi
final
destruct
effect
typic
associ
free
radic
damag
dna
blockag
blood
vessel
could
complic
use
approach
human
like
new
drug
increas
ro
product
might
unanticip
side
effect
whatev
outcom
drug
develop
effort
howev
studi
excel
remind
good
evil
biochemicalsin
intricaci
cellular
metabol
matter
balanc
